Home > Insider Trading > Incyte Corp

Incyte Corp (INCY)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
71 - 80
Next >>

Hedge Funds Say Just One of These Three Tuesday Movers is Worth Investing In

As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation (USA) (NYSE:ECA), Denbury Resources Inc.

Keep Reading →

October 6th, 2015 - Market Movers News

Data Show Hedge Funds Like One of these Two Volatile Healthcare Stocks More than the Other

Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions before both started above yesterday’s close...

Keep Reading →

September 29th, 2015 - Market Movers News

Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns

With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.

Keep Reading →

July 10th, 2015 - Hedge Funds News

Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks

Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.

Keep Reading →

March 5th, 2015 - Hedge Funds News

Baker Bros. Advisors Reduces Exposure to MEI Pharma Inc (MEIP) to 3.4%

Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.

Keep Reading →

January 2nd, 2014 - Hedge Funds News

The Baker Brothers Cut Their Position in Incyte Corporation

Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million shares, from some 30.20 million held earlier.

Keep Reading →

November 15th, 2013 - Hedge Funds News

Theravance Inc (THRX): Are Hedge Funds Right About This Stock?

At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 12th, 2013 - News

Veolia Environnement SA (ADR) (VE), Incyte Corporation (INCY), Cliffs Natural Resources Inc (CLF): 3 Great Downgrades You Should Know About

Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls.

Keep Reading →

September 11th, 2013 - News

Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?

At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.

Keep Reading →

September 10th, 2013 - News

Incyte Corporation (INCY), Pfizer Inc. (PFE): This Biotech Has So Many Reasons to Be Liked

Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only approved drug, Jakafi, which is used in the ...

Keep Reading →

September 6th, 2013 - News